Jharkhand Health Authority Suspends Hospital from Ayushman Bharat Scheme
The Jharkhand State Arogya Society has taken decisive action against Hazaribag Ford and Ortho Care, suspending the hospital from the Ayushman Bharat–Mukhyamantri Jan Arogya Yojana with immediate effect. This suspension follows allegations of serious irregularities and the hospital's failure to respond to multiple show-cause notices within the required timeframe, according to official sources.
Detection of Serious Discrepancies
Official investigations revealed that a comprehensive analysis report submitted by the National Insurance Company Limited identified significant discrepancies in the hospital's operations. These findings indicated clear violations of the established norms and guidelines governing the Ayushman Bharat healthcare scheme, which provides critical health coverage to millions of beneficiaries across the state.
Repeated Notices and Lack of Response
The Jharkhand State Arogya Society initiated formal proceedings by issuing show-cause notices to Hazaribag Ford and Ortho Care on three separate occasions:
- September 20, 2024
- May 30, 2025
- September 23, 2025
According to a detailed press note released by the state health department, the society communicated these notices through the hospital's registered official email address and followed up with subsequent reminders. Despite these repeated efforts, the hospital management completely failed to submit any explanation or clarification within the prescribed deadlines.
Immediate Suspension and Implications
The suspension means that Hazaribag Ford and Ortho Care can no longer provide services under the Ayushman Bharat–Mukhyamantri Jan Arogya Yojana until further notice. This action underscores the state government's commitment to maintaining strict compliance and transparency within its flagship healthcare program, ensuring that public funds are utilized appropriately and beneficiaries receive quality care without compromise.
Health authorities have emphasized that such measures are necessary to uphold the integrity of the scheme and protect the interests of patients who depend on these services for essential medical treatment. The suspension serves as a strong warning to other healthcare providers about the consequences of non-compliance with scheme regulations.
